{"id":207,"date":"2020-03-26T11:27:22","date_gmt":"2020-03-26T11:27:22","guid":{"rendered":"https:\/\/ch.alfasigma.com\/?page_id=207"},"modified":"2025-03-21T13:53:55","modified_gmt":"2025-03-21T13:53:55","slug":"ricerca-e-innovazione","status":"publish","type":"page","link":"https:\/\/ch.alfasigma.com\/it\/ricerca-e-innovazione\/","title":{"rendered":"Ricerca e innovazione"},"content":{"rendered":"\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t
<\/div>\n\t\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

R&D<\/p>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t

Guidati
\ndall\u2019innovazione<\/h1>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Il nostro dipartimento di Ricerca e Sviluppo si concentra su tre principali aree terapeutiche \u2013 gastroenterologia, malattie vascolari e neuroscienze \u2013 consolidando i prodotti esistenti e sviluppando nuove indicazioni terapeutiche per far fronte a bisogni insoddisfatti.<\/p>

Il recente piano strategico ci consentir\u00e0 di affrontare le sfide del settore sanitario nei prossimi decenni, sfruttando le opportunit\u00e0 della medicina di precisione<\/b>, massimizzando le competenze esistenti sul microbioma<\/b>, acquisendo nuove molecole<\/b> in fase avanzata di sviluppo.<\/p>

Alfasigma collabora inoltre con diverse organizzazioni partner per esplorare ulteriori opportunit\u00e0 attraverso big data, nuove tecnologie e progetti di coinvolgimento dei pazienti.\u00a0<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
Le principali linee di ricerca e sviluppo<\/h5>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\n\t\t\t\t\t\t<\/span>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
Pipeline<\/h5>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
Ciclo di vita<\/h5>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\n\t\t\t\t\t\t<\/span>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Gastroenterologia<\/p>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\n\t\t\t\t\t\t<\/span>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
Pipeline<\/h5>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

5 progetti
(3 in fase di sviluppo clinico)<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\n\t\t\t\t\t\t<\/span>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
Ciclo di vita<\/h5>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Normix, Tixteller, Xifaxan (rifaximina)<\/p>

Sviluppato interamente da Alfasigma<\/p>

Indicato per encefalopatia epatica, diarrea del viaggiatore, sindrome del colon irritabile<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\n\t\t\t\t\t\t<\/span>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Medicina vascolare<\/p>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\n\t\t\t\t\t\t<\/span>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
Pipeline<\/h5>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

1 progetto<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\n\t\t\t\t\t\t<\/span>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
Ciclo di vita<\/h5>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Vessel (Sulodexide)<\/p>

Sviluppato interamente da Alfasigma<\/p>

Indicato per patologie vascolari (CVI, rDVT) e arteriose (PAOD)<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\n\t\t\t\t\t\t<\/span>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Neuroscienza<\/p>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\n\t\t\t\t\t\t<\/span>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
Pipeline<\/h5>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Nuovi progetti in fase di valutazione<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\n\t\t\t\t\t\t<\/span>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
Ciclo di vita<\/h5>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Deplin (L-metilfolato)<\/p>

Indicato come integratore nel trattamento dei disturbi depressivi<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
Il microbioma come motore di ricerca e sviluppo\n<\/h5>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Rifaximina<\/p>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

\u00e8 uno dei pi\u00f9 efficaci modificatori di microbioma sul mercato<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t

\n\t\t\t
\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Sindrome del colon irritabile<\/p>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Encefalopatia epatica<\/p>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Nuove molecole<\/p>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t

\n\t\t\t
\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

In fase di esplorazione<\/p>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t

\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Scopri di pi\u00f9<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\n\t\t\t\t\t
\n\t\t\t\t
<\/div>\n\t\t\t\t
<\/div>\n\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Prodotti<\/a><\/h4>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Alfasigma ha un ampio portafoglio di prodotti che tratta varie malattie.\u00a0<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t

\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\n\t\t\t\t\t
\n\t\t\t\t
<\/div>\n\t\t\t\t
<\/div>\n\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Farmacovigilanza<\/a><\/h4>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Segnalare le reazioni avverse dei farmaci \u00e8 fondamentale per proteggere i pazienti che li assumono e assicurare un rapporto tra benefici e rischi favorevole per la popolazione.\u00a0<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t

\n\t\t\t
\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"

R&D Guidati dall\u2019innovazione Il nostro dipartimento di Ricerca e Sviluppo si concentra su tre principali aree terapeutiche \u2013 gastroenterologia, malattie vascolari e neuroscienze \u2013 consolidando i prodotti esistenti e sviluppando nuove indicazioni terapeutiche per far fronte a bisogni insoddisfatti. Il recente piano strategico ci consentir\u00e0 di affrontare le sfide del settore sanitario nei prossimi decenni, … Continued<\/a><\/p>\n","protected":false},"author":1,"featured_media":2848,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"views\/template-custom.blade.php","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-207","page","type-page","status-publish","has-post-thumbnail","hentry"],"acf":[],"yoast_head":"\nAlfasigma Schweiz - Ricerca e innovazione<\/title>\n<meta name=\"description\" content=\"Il dipartimento R&D Alfasigma si concentra su 3 principali aree terapeutiche: gastroenterologia, malattie vascolari, disturbi neuroscientifici\" \/>\n<meta name=\"robots\" content=\"index,follow\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ch.alfasigma.com\/it\/ricerca-e-innovazione\/\" \/>\n<meta property=\"og:locale\" content=\"it_IT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Alfasigma Schweiz - Ricerca e innovazione\" \/>\n<meta property=\"og:description\" content=\"Il dipartimento R&D Alfasigma si concentra su 3 principali aree terapeutiche: gastroenterologia, malattie vascolari, disturbi neuroscientifici\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ch.alfasigma.com\/it\/ricerca-e-innovazione\/\" \/>\n<meta property=\"og:site_name\" content=\"Alfasigma Schweiz\" \/>\n<meta property=\"article:modified_time\" content=\"2025-03-21T13:53:55+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ch.alfasigma.com\/wp-content\/uploads\/2020\/11\/CNRP6093_RD-Lab-foto-per-top-pagina-con-etichetta.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1080\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ch.alfasigma.com\\\/it\\\/ricerca-e-innovazione\\\/\",\"url\":\"https:\\\/\\\/ch.alfasigma.com\\\/it\\\/ricerca-e-innovazione\\\/\",\"name\":\"Alfasigma Schweiz - Ricerca e innovazione\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ch.alfasigma.com\\\/it\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/ch.alfasigma.com\\\/it\\\/ricerca-e-innovazione\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/ch.alfasigma.com\\\/it\\\/ricerca-e-innovazione\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ch.alfasigma.com\\\/wp-content\\\/uploads\\\/2020\\\/11\\\/CNRP6093_RD-Lab-foto-per-top-pagina-con-etichetta.jpg\",\"datePublished\":\"2020-03-26T11:27:22+00:00\",\"dateModified\":\"2025-03-21T13:53:55+00:00\",\"description\":\"Il dipartimento R&D Alfasigma si concentra su 3 principali aree terapeutiche: gastroenterologia, malattie vascolari, disturbi neuroscientifici\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ch.alfasigma.com\\\/it\\\/ricerca-e-innovazione\\\/#breadcrumb\"},\"inLanguage\":\"it-CH\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ch.alfasigma.com\\\/it\\\/ricerca-e-innovazione\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"it-CH\",\"@id\":\"https:\\\/\\\/ch.alfasigma.com\\\/it\\\/ricerca-e-innovazione\\\/#primaryimage\",\"url\":\"https:\\\/\\\/ch.alfasigma.com\\\/wp-content\\\/uploads\\\/2020\\\/11\\\/CNRP6093_RD-Lab-foto-per-top-pagina-con-etichetta.jpg\",\"contentUrl\":\"https:\\\/\\\/ch.alfasigma.com\\\/wp-content\\\/uploads\\\/2020\\\/11\\\/CNRP6093_RD-Lab-foto-per-top-pagina-con-etichetta.jpg\",\"width\":1920,\"height\":1080},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ch.alfasigma.com\\\/it\\\/ricerca-e-innovazione\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/ch.alfasigma.com\\\/it\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ricerca e innovazione\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ch.alfasigma.com\\\/it\\\/#website\",\"url\":\"https:\\\/\\\/ch.alfasigma.com\\\/it\\\/\",\"name\":\"Alfasigma Schweiz\",\"description\":\"Pharmaceuticals with passion\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ch.alfasigma.com\\\/it\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"it-CH\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Alfasigma Schweiz - Ricerca e innovazione","description":"Il dipartimento R&D Alfasigma si concentra su 3 principali aree terapeutiche: gastroenterologia, malattie vascolari, disturbi neuroscientifici","robots":{"index,follow":"index,follow"},"canonical":"https:\/\/ch.alfasigma.com\/it\/ricerca-e-innovazione\/","og_locale":"it_IT","og_type":"article","og_title":"Alfasigma Schweiz - Ricerca e innovazione","og_description":"Il dipartimento R&D Alfasigma si concentra su 3 principali aree terapeutiche: gastroenterologia, malattie vascolari, disturbi neuroscientifici","og_url":"https:\/\/ch.alfasigma.com\/it\/ricerca-e-innovazione\/","og_site_name":"Alfasigma Schweiz","article_modified_time":"2025-03-21T13:53:55+00:00","og_image":[{"width":1920,"height":1080,"url":"https:\/\/ch.alfasigma.com\/wp-content\/uploads\/2020\/11\/CNRP6093_RD-Lab-foto-per-top-pagina-con-etichetta.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/ch.alfasigma.com\/it\/ricerca-e-innovazione\/","url":"https:\/\/ch.alfasigma.com\/it\/ricerca-e-innovazione\/","name":"Alfasigma Schweiz - Ricerca e innovazione","isPartOf":{"@id":"https:\/\/ch.alfasigma.com\/it\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ch.alfasigma.com\/it\/ricerca-e-innovazione\/#primaryimage"},"image":{"@id":"https:\/\/ch.alfasigma.com\/it\/ricerca-e-innovazione\/#primaryimage"},"thumbnailUrl":"https:\/\/ch.alfasigma.com\/wp-content\/uploads\/2020\/11\/CNRP6093_RD-Lab-foto-per-top-pagina-con-etichetta.jpg","datePublished":"2020-03-26T11:27:22+00:00","dateModified":"2025-03-21T13:53:55+00:00","description":"Il dipartimento R&D Alfasigma si concentra su 3 principali aree terapeutiche: gastroenterologia, malattie vascolari, disturbi neuroscientifici","breadcrumb":{"@id":"https:\/\/ch.alfasigma.com\/it\/ricerca-e-innovazione\/#breadcrumb"},"inLanguage":"it-CH","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ch.alfasigma.com\/it\/ricerca-e-innovazione\/"]}]},{"@type":"ImageObject","inLanguage":"it-CH","@id":"https:\/\/ch.alfasigma.com\/it\/ricerca-e-innovazione\/#primaryimage","url":"https:\/\/ch.alfasigma.com\/wp-content\/uploads\/2020\/11\/CNRP6093_RD-Lab-foto-per-top-pagina-con-etichetta.jpg","contentUrl":"https:\/\/ch.alfasigma.com\/wp-content\/uploads\/2020\/11\/CNRP6093_RD-Lab-foto-per-top-pagina-con-etichetta.jpg","width":1920,"height":1080},{"@type":"BreadcrumbList","@id":"https:\/\/ch.alfasigma.com\/it\/ricerca-e-innovazione\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ch.alfasigma.com\/it\/"},{"@type":"ListItem","position":2,"name":"Ricerca e innovazione"}]},{"@type":"WebSite","@id":"https:\/\/ch.alfasigma.com\/it\/#website","url":"https:\/\/ch.alfasigma.com\/it\/","name":"Alfasigma Schweiz","description":"Pharmaceuticals with passion","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ch.alfasigma.com\/it\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"it-CH"}]}},"_links":{"self":[{"href":"https:\/\/ch.alfasigma.com\/it\/wp-json\/wp\/v2\/pages\/207","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ch.alfasigma.com\/it\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/ch.alfasigma.com\/it\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/ch.alfasigma.com\/it\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/ch.alfasigma.com\/it\/wp-json\/wp\/v2\/comments?post=207"}],"version-history":[{"count":3,"href":"https:\/\/ch.alfasigma.com\/it\/wp-json\/wp\/v2\/pages\/207\/revisions"}],"predecessor-version":[{"id":7804,"href":"https:\/\/ch.alfasigma.com\/it\/wp-json\/wp\/v2\/pages\/207\/revisions\/7804"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ch.alfasigma.com\/it\/wp-json\/wp\/v2\/media\/2848"}],"wp:attachment":[{"href":"https:\/\/ch.alfasigma.com\/it\/wp-json\/wp\/v2\/media?parent=207"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}